Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?

被引：0
作者：
Glueck, Charles J. [1 ]
机构：
[1] Cholesterol Metab & Thrombosis Res Ctr, 3906 Middleton Ave, Cincinnati, OH 45220 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2024年 / 110卷 / 03期
关键词：
Turner's syndrome; insulin resistance; glucagon-like peptide 1; glucose-dependent insulinotropic polypeptide; DUAL GIP; TIRZEPATIDE;
D O I：
10.1210/clinem/dgae435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e901 / e902
页数：2
相关论文
共 8 条
[1]   Characterization of Turner Syndrome-associated Diabetes Mellitus [J].
Cameron-Pimblett, Antoinette ;
La Rosa, Clementina ;
Davies, Melanie C. ;
Suntharalingham, Jenifer P. ;
Ishida, Miho ;
Achermann, John C. ;
Conway, Gerard S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025, 110 (05) :1279-1286
[2]   INSULIN RESISTANCE - AN EARLY METABOLIC DEFECT OF TURNERS SYNDROME [J].
CAPRIO, S ;
BOULWARE, S ;
DIAMOND, M ;
SHERWIN, RS ;
CARPENTER, TO ;
RUBIN, K ;
AMIEL, S ;
PRESS, M ;
TAMBORLANE, WV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (04) :832-836
[3]   Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists [J].
Cena, Hellas ;
Chiovato, Luca ;
Nappi, Rossella E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08) :E2695-E2709
[4]   Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics [J].
Glueck, Charles J. ;
Goldenberg, Naila .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 92 :108-120
[5]   Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes [J].
Lincoff, A. Michael ;
Brown-Frandsen, Kirstine ;
Colhoun, Helen M. ;
Deanfield, John ;
Emerson, Scott S. ;
Esbjerg, Sille ;
Hardt-Lindberg, Soren ;
Hovingh, G. Kees ;
Kahn, Steven E. ;
Kushner, Robert F. ;
Lingvay, Ildiko ;
Oral, Tugce K. ;
Michelsen, Marie M. ;
Plutzky, Jorge ;
Tornoe, Christoffer W. ;
Ryan, Donna H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24) :2221-2232
[6]   Effects of Tirzepatide, a Dual GIP and GLP-1 RA, on Lipid and Metabolite Profiles in Subjects With Type 2 Diabetes [J].
Pirro, Valentina ;
Roth, Kenneth D. ;
Lin, Yanzhu ;
Willency, Jill A. ;
Milligan, Paul L. ;
Wilson, Jonathan M. ;
Ruotolo, Giacomo ;
Haupt, Axel ;
Newgard, Christopher B. ;
Duffin, Kevin L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (02) :363-378
[7]   Cardiovascular Health in Turner Syndrome A Scientific Statement From the American Heart Association [J].
Silberbach, Michael ;
Roos-Hesselink, Jolien W. ;
Andersen, Niels H. ;
Braverman, Alan C. ;
Brown, Nicole ;
Collins, R. Thomas ;
De Backer, Julie ;
Eagle, Kim A. ;
Hiratzka, Loren F. ;
Johnson, Walter H., Jr. ;
Kadian-Dodov, Daniella ;
Lopez, Leo ;
Mortensen, Kristian H. ;
Prakash, Siddharth K. ;
Ratchford, Elizabeth V. ;
Saidi, Arwa ;
van Hagen, Iris ;
Young, Luciana T. .
CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (10) :e000048
[8]   Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes [J].
Thomas, Melissa K. ;
Nikooienejad, Amir ;
Bray, Ross ;
Cui, Xuewei ;
Wilson, Jonathan ;
Duffin, Kevin ;
Milicevic, Zvonko ;
Haupt, Axel ;
Robins, Deborah A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02) :388-396
1